Bridgeway Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Bridgeway Capital Management’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,507	Closed	-$657K	–	1405
2022 Q1	$657K	Sell	20,507 -40,000	-66%	-$1.15M	0.01%	875
2021 Q4	$1.31M	Hold	60,507	–	–	0.02%	735
2021 Q3	$1.33M	Hold	60,507	–	–	0.03%	747
2021 Q2	$1.18M	Sell	60,507 -7,500	-11%	-$136K	0.02%	806
2021 Q1	$1.17M	Buy	68,007 +14,300	+27%	+$226K	0.02%	801
2020 Q4	$861K	Hold	53,707	–	–	0.02%	780
2020 Q3	$573K	Buy	53,707 +18,800	+54%	+$224K	0.01%	839
2020 Q2	$425K	Buy	+34,907	New	+$433K	0.01%	905
2019 Q4	–	Sell	-8,110	Closed	-$106K	–	1412
2019 Q3	$127K	Sell	8,110 -1,250	-13%	-$23.9K	﹤0.01%	1229
2019 Q2	$210K	Sell	9,360 -3,843	-29%	-$186K	﹤0.01%	1170
2019 Q1	$903K	Buy	13,203 +5,703	+76%	+$366K	0.01%	796
2018 Q4	$396K	Buy	7,500 +1,875	+33%	+$120K	0.01%	1070
2018 Q3	$383K	Buy	5,625 +1,517	+37%	+$138K	﹤0.01%	1202
2018 Q2	$486K	Sell	4,108 -1,250	-23%	-$125K	﹤0.01%	1144
2018 Q1	$444K	Buy	5,358 +1,250	+30%	+$142K	﹤0.01%	1127
2017 Q4	$613K	Hold	4,108	–	–	0.01%	1034
2017 Q3	$255K	Buy	4,108 +750	+22%	+$44K	﹤0.01%	1237
2017 Q2	$157K	Hold	3,358	–	–	﹤0.01%	1324
2017 Q1	$205K	Sell	3,358 -3,650	-52%	-$212K	﹤0.01%	1276
2016 Q4	$418K	Sell	7,008 -1,375	-16%	-$85.7K	0.01%	1142
2016 Q3	$610K	Buy	8,383 +7,008	+510%	+$542K	0.01%	997
2016 Q2	$109K	Buy	+1,375	New	+$262K	﹤0.01%	1378

Other funds holding SRRA

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bridgeway Capital Management's SRRA Position: Q2 2022 in Review

Bridgeway Capital Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2022, closing a stake of 20,507 shares — an estimated $657K sold.

Bridgeway Capital Management first reported a position in SRRA in Q2 2016 and held it in 22 quarters. The position peaked at $1.33M in Q3 2021. 109 funds tracked by Wall St. Rank hold SRRA as of Q2 2022.

Bridgeway Capital Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Bridgeway Capital Management sold 20,507 Sierra Oncology, Inc. Common Stock shares in Q2 2022, an estimated $657K.
Bridgeway Capital Management first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2016 and held it in 22 quarters.
Bridgeway Capital Management's Sierra Oncology, Inc. Common Stock position peaked at $1.33M in Q3 2021.
109 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2022.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.